Stockscreener 앱 받기
1.80
1.12%
0.02
Milestone Pharmaceuticals Inc (MIST) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Research and Development |
26.30%
3.669
|
4.978 | 3.94 | 3.963 | 2.815 |
| Operating Income/Loss |
38.94%
-12.53
|
-20.52 | -12.35 | -9.616 | -9.662 |
| Income/Loss From Continuing Operations Before Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Income/Loss From Continuing Operations After Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
Net Income/Loss
|
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Diluted Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
자본화:
|
볼륨(24시간):